FIGURE 4.
Median time to tumour progression in patients randomly assigned to receive 25 mg, 75 mg, or 250 mg of CCI-779 (temsirolimus) weekly 29.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.